Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

A Phase II multi-institutional trial of chemoradiation using weekly docetaxel and erythropoietin for high-risk postoperative head and neck cancer patients.

Willey CD, Murphy BA, Netterville JL, Burkey BB, Shyr Y, Shakhtour B, Kish B, Raben D, Chen C, Song JI, Kane MA, Cmelak AJ.

Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1323-31. Epub 2007 Feb 7.

PMID:
17289289
2.

Docetaxel with concurrent radiotherapy in head and neck cancer.

Nabell L, Spencer S.

Semin Oncol. 2003 Dec;30(6 Suppl 18):89-93. Review.

PMID:
14727247
3.

Treatment of head and neck cancers: issues for clinical pharmacists.

Scarpace SL, Brodzik FA, Mehdi S, Belgam R.

Pharmacotherapy. 2009 May;29(5):578-92. doi: 10.1592/phco.29.5.578. Review.

PMID:
19397465
4.

[Recall dermatitis caused by re-exposure to docetaxel following irradiation of the brain. Case report and review of the literature].

Giesel BU, Kutz GG, Thiel HJ.

Strahlenther Onkol. 2001 Sep;177(9):487-93. Review. German.

PMID:
11591023
5.

Oral mucositis.

Raber-Durlacher JE, Elad S, Barasch A.

Oral Oncol. 2010 Jun;46(6):452-6. doi: 10.1016/j.oraloncology.2010.03.012. Epub 2010 Apr 18. Review.

PMID:
20403721
6.

Management of 'in-field' skin toxicity in head and neck cancer patients treated with combined cetuximab and radiotherapy.

Cante D, La Porta MR, Franco P, Sciacero P, Girelli GF, Marra A, Numico G, Denaro N, Russi EG, Ricardi U.

Oncology. 2013;85(5):257-61. doi: 10.1159/000355579. Epub 2013 Oct 29. Review.

7.

Radiation recall dermatitis after docetaxel administration: absolute indication to replace the drug?

Borgia F, Guarneri C, Guarneri F, Vaccaro M.

Br J Dermatol. 2005 Sep;153(3):674-5. Review. No abstract available.

PMID:
16120169
8.

Management of head and neck cancer in elderly patients.

Lalami Y, de Castro G Jr, Bernard-Marty C, Awada A.

Drugs Aging. 2009;26(7):571-83. doi: 10.2165/11316340-000000000-00000. Review.

PMID:
19655824
9.

Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis.

Elting LS, Chang YC, Parelkar P, Boers-Doets CB, Michelet M, Hita G, Rouleau T, Cooksley C, Halm J, Vithala M, Bossi P, Escalante C, Brennan MT; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2013 Nov;21(11):3243-54. doi: 10.1007/s00520-013-1821-8. Epub 2013 May 2. Review.

PMID:
23636648

Supplemental Content

Support Center